Publisher
Springer Science and Business Media LLC
Subject
Microbiology (medical),Microbiology,Infectious Diseases,Microbiology (medical),General Medicine
Reference8 articles.
1. Barlem, T., Neu, H. C.: In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy 1984, 25: 529–531.
2. Jones, R. N., Barry, A. L., Thornsberry, C.: In vitro evaluation of three new macrolide antimicrobial agents, RU 28965, RU 29065, and RU 29702, and comparisons with other orally administered drugs. Antimicrobial Agents and Chemotherapy 1983, 24: 209–215.
3. Jorgensen, J. H., Redding, J. S., Howell, A. W.: In vitro activity of the new macrolide antibiotic, roxithromycin (RU 28965), against clinical isolates ofHaemophilus influenzae. Antimicrobial Agents and Chemotherapy 1986, 29: 921–922.
4. Rolston, K. V. I., Le Blanc, B., Ho, D. H.: In vitro activity of RU 28965, a new macrolide, compared to that of erythromycin. Journal of Antimicrobial Chemotherapy 1986, 17: 161–163.
5. Lassman, H. B., Puri, S. K., Ho, I., Sabo, R., Barry, A.: Influence of food on the absorption of RU 28965 (a new macrolide antibiotic) from film-coated tablets in healthy men. In: Butzler, J. P., Kobayashi, H. (ed.): Macrolides: a review with an outlook on future developments. Excerpta Medica, Geneva, 1986, p. 138–142.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献